Based on our in vivo data showing increased EPOR and decreased EPO in a transgenic mouse model of AD in comparison with their age-matched WT controls and increase in EPO and EPOR induced by aging in both normal and AD mice it can be suggested that EPO and EPOR can serve as possible markers of brain cell vulnerability during aging and Alzheimer’s pathology. This evidence concerns the gene EPO and Alzheimer disease.